Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS MDI vs Proventil in mild to moderate asthma (ASPEN)
NCT03371459Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of salbutamol in asthma, sponsored by AstraZeneca. Started Dec 2017; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03371459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371459.